Google News

Full Coverage

News about weight loss • GLP-1

Top news

Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug

Jun 21

By Amber Tong

Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss

Jun 21

By Heidi Splete

Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025

Jun 23

Ecnoglutide, a novel GLP-1, safe and effective for treatment of overweight, obesity

Jun 22

All coverage

China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds

Jun 21

By Michael Erman, Caroline Humer & Rosalba O'Brien

Endocrinology Advisor

ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight

Jun 27

New weight-loss drug sails through all-important Phase III trial

Jun 21

By Bronwyn Thompson

U.S. News & World Report

Rival GLP-1 Weight-Loss Drug Emerges From China

Jun 24

Ecnoglutide yields superior, sustained reduction in body weight: Study

Jun 23

southernminn.com

Rival GLP-1 Weight-Loss Drug Emerges From China

Jun 24

China’s Sciwind eyes 10% share in obesity drug market | Tap to know more | Inshorts

Jun 23

Sciwind Biosciences showcases challenger to obesity drugs, Bloomberg says

Jun 22

China’s Sciwind’s GLP-1 shows similar weight loss to Novo’s Wegovy, study finds

Jun 21

By Michael Erman, Caroline Humer & Rosalba O'Brien

Search

Clear search

Close search

Google apps

Main menu